DK1228093T3 - Forbedring af peptidtransport ved hjælp af konjugation med galdesyrer - Google Patents

Forbedring af peptidtransport ved hjælp af konjugation med galdesyrer

Info

Publication number
DK1228093T3
DK1228093T3 DK00948177T DK00948177T DK1228093T3 DK 1228093 T3 DK1228093 T3 DK 1228093T3 DK 00948177 T DK00948177 T DK 00948177T DK 00948177 T DK00948177 T DK 00948177T DK 1228093 T3 DK1228093 T3 DK 1228093T3
Authority
DK
Denmark
Prior art keywords
enhancement
bile acid
peptide transport
acid conjugation
conjugation
Prior art date
Application number
DK00948177T
Other languages
Danish (da)
English (en)
Inventor
Sarah Wheeler
James Duncan Morrison
Michael Leslie Lucas
Original Assignee
James Duncan Morrison
Sarah Wheeler
Michael Leslie Lucas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James Duncan Morrison, Sarah Wheeler, Michael Leslie Lucas filed Critical James Duncan Morrison
Application granted granted Critical
Publication of DK1228093T3 publication Critical patent/DK1228093T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00948177T 1999-07-30 2000-07-28 Forbedring af peptidtransport ved hjælp af konjugation med galdesyrer DK1228093T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9917793A GB2355009A (en) 1999-07-30 1999-07-30 Peptides conjugated to bile acids/salts
PCT/GB2000/002903 WO2001009163A2 (fr) 1999-07-30 2000-07-28 Transport de peptides

Publications (1)

Publication Number Publication Date
DK1228093T3 true DK1228093T3 (da) 2007-05-14

Family

ID=10858148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00948177T DK1228093T3 (da) 1999-07-30 2000-07-28 Forbedring af peptidtransport ved hjælp af konjugation med galdesyrer

Country Status (8)

Country Link
US (1) US7153930B1 (fr)
EP (1) EP1228093B1 (fr)
AU (1) AU6173900A (fr)
DE (1) DE60032926T2 (fr)
DK (1) DK1228093T3 (fr)
ES (1) ES2280232T3 (fr)
GB (1) GB2355009A (fr)
WO (1) WO2001009163A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2670787B1 (fr) * 1990-12-18 1995-06-23 Pasteur Institut Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.
AU2002211538A1 (en) * 2000-10-06 2002-04-15 Xenoport, Inc. Compounds for sustained release of orally delivered drugs
AU2002243204A1 (en) 2000-10-06 2002-06-11 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
GB0105069D0 (en) * 2001-03-01 2001-04-18 Univ Ulster The Modified peptide
ES2271255T3 (es) * 2001-05-02 2007-04-16 Novo Nordisk A/S Preparacion de acidos biliares.
EP1465598A4 (fr) 2001-12-21 2006-12-20 David S Soane Utilisation d'oligomeres et de polymeres pour solubiliser, stabiliser et distribuer un medicament
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
CA2512310C (fr) * 2003-01-13 2012-09-25 Bracco Imaging S.P.A. Lieurs ameliores pour composes pharmaceutiques
JP4896870B2 (ja) * 2004-04-08 2012-03-14 ヤード・テヒノロギース・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 細胞膜ラフトと相互作用する構造を含む三者複合体およびその使用
ATE442865T1 (de) * 2004-04-08 2009-10-15 Jado Technologies Gmbh Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung
CA2613619A1 (fr) 2005-07-07 2007-01-18 Fulcrum Sp Ltd. Polypeptides sp1, polypeptides sp1 modifies et leurs utilisations
AU2009279090A1 (en) * 2008-08-06 2010-02-11 Novo Nordisk Health Care Ag Conjugated proteins with prolonged in vivo efficacy
GB0817969D0 (en) 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
CA2747825A1 (fr) 2009-01-22 2010-07-29 Novo Nordisk Health Care Ag Composes stables d'hormone de croissance
EP2461831B1 (fr) 2009-08-06 2018-11-21 Novo Nordisk Health Care AG Hormones de croissance ayant une efficacité in vivo prolongée
RU2012134974A (ru) 2010-01-22 2014-02-27 Ново Нордиск Хелс Кеа Аг Стабилизированное соединение гормона роста
RU2605627C2 (ru) 2010-01-22 2016-12-27 Ново Нордиск Хелс Кеа Аг Гормоны роста с пролонгированной эффективностью in vivo
US8575124B2 (en) 2010-02-18 2013-11-05 Anthony P. Shuber Compositions and methods for treating cancer
JP2013533264A (ja) * 2010-07-22 2013-08-22 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 成長ホルモンコンジュゲート
EP2981282B1 (fr) 2013-04-05 2020-11-04 Novo Nordisk Health Care AG Formulation d'un composé d'hormone de croissance
KR102470291B1 (ko) 2014-10-31 2022-11-28 유니버시티 오브 유타 리서치 파운데이션 담즙산 입자를 위한 조성물 및 방법
IL243839B (en) 2016-01-28 2018-01-31 Sp Nano Ltd Conductive wires
IL243838A (en) 2016-01-28 2017-07-31 Sp Nano Ltd The composition containing sp1 protein and carbon nanoparticles and its uses
EP3429599B1 (fr) 2016-03-16 2024-02-07 Georgetown University Nanoparticule pour cibler un cancer
CA3168207A1 (fr) 2020-01-23 2021-07-29 Axcess (Uk) Ltd. Absorption cellulaire
CN113321699B (zh) * 2021-05-08 2024-07-19 武汉桀升生物科技有限公司 鹅肌肽胆酸盐的制备方法以及其用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5446026A (en) * 1989-08-09 1995-08-29 Advanced Peptides & Biotechnology Sciences Potent non-opiate analgesic
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
CA2135194A1 (fr) 1992-05-22 1993-12-09 Charles L. Bevins Defensines gastrointestinales, sequences d'adnc et methode d'obtention et d'emploi
DK0573848T3 (da) 1992-06-12 1998-08-10 Hoechst Ag Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
JP3687993B2 (ja) * 1994-06-24 2005-08-24 シスメックス株式会社 インシュリン標準液
GB9417524D0 (en) 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
DE4432708A1 (de) 1994-09-14 1996-03-21 Hoechst Ag Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5861494A (en) 1995-06-06 1999-01-19 Human Genome Sciences, Inc. Colon specific gene and protein
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
GB9614235D0 (en) 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US6171816B1 (en) 1996-08-23 2001-01-09 Human Genome Sciences, Inc. Human XAG-1 polynucleotides and polypeptides
US5837841A (en) 1996-10-11 1998-11-17 Incyte Pharmaceuticals, Inc. Human Reg protein
US5929033A (en) 1998-02-10 1999-07-27 Incyte Pharmaceuticals, Inc. Extracellular mucous matrix glycoprotein
KR100314496B1 (ko) * 1998-05-28 2001-11-22 윤동진 항혈전성이 있는 헤파린 유도체, 그의 제조방법 및 용도
RU2224523C2 (ru) * 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
WO2001022920A2 (fr) 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Polynucleotides et polypeptides associes au colon et au cancer du colon

Also Published As

Publication number Publication date
EP1228093A2 (fr) 2002-08-07
ES2280232T3 (es) 2007-09-16
AU6173900A (en) 2001-02-19
US7153930B1 (en) 2006-12-26
GB2355009A (en) 2001-04-11
GB9917793D0 (en) 1999-09-29
WO2001009163A2 (fr) 2001-02-08
DE60032926D1 (de) 2007-02-22
EP1228093B1 (fr) 2007-01-10
WO2001009163A3 (fr) 2001-09-07
DE60032926T2 (de) 2007-10-25

Similar Documents

Publication Publication Date Title
DK1427423T3 (da) Benzothiazepin- og benzothiadiazepinderivater med ileal galdesyretransport- (IBAT) inhiberende aktivitet til behandling af hyperlipidæmi
EE200300088A (et) Imidasolo-5-üül-2-anilino-pürimidiinid raku proliferatsiooni inhibitsiooni agensitena
NO20013850D0 (no) Sulfamat hydroksansyremetallproteaseinhibitor
ATE246674T1 (de) Neue 3-aryl-2-hydroxypropionsäure-derivate
NO20010604D0 (no) Hepatitt C inhibitorpeptider
EE200100358A (et) Meetod ja komplekt prioonivalgu ekstraheerimiseks
DK1192125T3 (da) Mono-substituerede 3-propyl-gamma-aminosmörsyrer
FI990679A0 (fi) I/Q-modulaattorin tasajännitesiirtymän korjaus
ATE261429T1 (de) Neue 3-aryl-2-hydroxypropionsäure-derivate iii
ID29149A (id) Komposisi adjuvan
ATA206799A (de) Leuchtdioden-signalgeberoptik
DK1114641T3 (da) Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
ATE337307T1 (de) Neue dihydroxyhexansäurederivate
DE50007899D1 (de) Beta-alaninderivate
ATE339772T1 (de) Mehrpoliger elektromagnetischer schaltmodul
ATE339438T1 (de) Substanziell kristalline form von melagatran
EP1072264A4 (fr) Remedes contre la cirrhose biliaire primitive
DK0878606T3 (da) Formindskelse af metalkorrosivitet af organiske syrer
DE60016353D1 (de) Schmelzfixierband
FR2794495B1 (fr) Demarreur
DE60139893D1 (de) Neue fructosyl-aminosäureoxidase
DE60042364D1 (de) Neue amidasegene
FI991337L (fi) Suksisauva
EP1246635A4 (fr) Peptides designes superfamille o- de conotoxines